Progression-free and overall survival is significantly shorter in patients expressing high levels of KCNQ1OT1 than in patients expressing low levels of KCNQ1OT1, suggesting it may be a potential molecular marker for assessing prognosis in NSCLC [62]. This evidence concerns the gene KCNQ1OT1 and non-small cell lung carcinoma.